Baxter International news
The WiseView Research desk's stories that name Baxter International, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The BAX page →
- HeadlineWill Baxter's Q3 Earnings Show Progress Despite Cost Pressures?
- Week aheadWeek Ahead: Fed Decision, GDP, PCE Inflation and Peak Earnings Week
The Fed's rate decision, Q3 GDP and core PCE inflation headline a week in which 178 S&P 500 companies report earnings.
- HeadlineBaxter International: The Vantive Transition Complicates Margin Recovery
- HeadlineBaxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors
- HeadlineAre Investors Undervaluing Baxter International (BAX) Right Now?
- HeadlineIs Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
- HeadlineWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
- CongressRo Khanna bought $1,001 - $15,000 of BAX
- CongressMichael McCaul bought $15,001 - $50,000 of BAX
- CongressMichael McCaul bought $50,001 - $100,000 of BAX
- CongressLisa McClain bought $1,001 - $15,000 of BAX
- CongressLisa McClain sold $1,001 - $15,000 of BAX
- CongressLisa McClain sold $1,001 - $15,000 of BAX
- CongressLisa McClain bought $1,001 - $15,000 of BAX
- CongressRo Khanna bought $1,001 - $15,000 of BAX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.